These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16961594)

  • 1. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.
    Dentali F; Ageno W; Crowther M
    J Thromb Haemost; 2006 Sep; 4(9):1853-63. PubMed ID: 16961594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review.
    Dentali F; Ageno W
    Haematologica; 2004 Jul; 89(7):857-62. PubMed ID: 15257939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of warfarin-associated coagulopathy with vitamin K.
    Patriquin C; Crowther M
    Expert Rev Hematol; 2011 Dec; 4(6):657-65; quiz 666-7. PubMed ID: 22077529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.
    Crowther MA; Douketis JD; Schnurr T; Steidl L; Mera V; Ultori C; Venco A; Ageno W
    Ann Intern Med; 2002 Aug; 137(4):251-4. PubMed ID: 12186515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled trial of orally administered vitamin K1 for warfarin-associated coagulopathy in Chinese patients with mechanical heart valves.
    Zhang H; Li M; Ao XL; Dong YJ; Dong L
    Eur J Clin Pharmacol; 2021 Sep; 77(9):1333-1339. PubMed ID: 33783553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.
    Dezee KJ; Shimeall WT; Douglas KM; Shumway NM; O'malley PG
    Arch Intern Med; 2006 Feb; 166(4):391-7. PubMed ID: 16505257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study.
    Al Sulaiman K; Al Mutairi M; Al Harbi O; Al Duraihim A; Aldosary S; Al Khalil H; Al Shaya A; Al Harbi S; Alotaibi N; Al Aamer K; Vishwakarma R; Al Asiri M; Aljuhani O; Al Katheri A; Al Bekairy AM
    Clin Appl Thromb Hemost; 2021; 27():10760296211050923. PubMed ID: 34806430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of vitamin K in patients on anticoagulant therapy: a practical guide.
    Hanslik T; Prinseau J
    Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations.
    Bahouth MN; Kraus P; Dane K; Plazas Montana M; Tsao W; Tabaac B; Jasem J; Schmidlin H; Einstein E; Streiff MB; Shanbhag S
    Medicine (Baltimore); 2019 Sep; 98(36):e17015. PubMed ID: 31490385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Factor versus 4-Factor Prothrombin Complex Concentrates for the Reversal of Vitamin K Antagonist-Associated Coagulopathy: A Systematic Review and Meta-analysis.
    Puchstein D; Kork F; Schöchl H; Rayatdoost F; Grottke O
    Thromb Haemost; 2023 Jan; 123(1):40-53. PubMed ID: 36626899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocolized use of Factor Eight Inhibitor Bypassing Activity (FEIBA) for the reversal of warfarin induced coagulopathy.
    Htet NN; Barounis D; Knight C; Umunna BP; Hormese M; Lovell E
    Am J Emerg Med; 2020 Mar; 38(3):539-544. PubMed ID: 31176578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid response to intravenous vitamin K may obviate the need to transfuse prothrombin complex concentrates.
    Sahai T; Tavares MF; Sweeney JD
    Transfusion; 2017 Aug; 57(8):1885-1890. PubMed ID: 28543073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois.
    Kelkar AH; Smith NA; Martial A; Moole H; Tarantino MD; Roberts JC
    N Engl J Med; 2018 Sep; 379(13):1216-1223. PubMed ID: 30280655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
    Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
    Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.